首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1166067篇
  免费   73618篇
  国内免费   1367篇
耳鼻咽喉   15698篇
儿科学   37437篇
妇产科学   29982篇
基础医学   164826篇
口腔科学   30017篇
临床医学   100676篇
内科学   222354篇
皮肤病学   24832篇
神经病学   90848篇
特种医学   47138篇
外国民族医学   201篇
外科学   179046篇
综合类   22467篇
现状与发展   1篇
一般理论   263篇
预防医学   82979篇
眼科学   25537篇
药学   91043篇
  7篇
中国医学   2810篇
肿瘤学   72890篇
  2019年   7764篇
  2018年   21960篇
  2017年   17597篇
  2016年   20443篇
  2015年   11633篇
  2014年   15522篇
  2013年   22434篇
  2012年   33434篇
  2011年   41744篇
  2010年   26482篇
  2009年   23412篇
  2008年   39859篇
  2007年   44351篇
  2006年   32933篇
  2005年   33085篇
  2004年   32182篇
  2003年   32197篇
  2002年   29934篇
  2001年   60328篇
  2000年   61972篇
  1999年   51133篇
  1998年   12636篇
  1997年   11240篇
  1996年   11178篇
  1995年   10485篇
  1994年   9514篇
  1993年   9001篇
  1992年   37922篇
  1991年   36417篇
  1990年   35879篇
  1989年   34407篇
  1988年   30977篇
  1987年   30115篇
  1986年   28317篇
  1985年   26555篇
  1984年   19253篇
  1983年   16185篇
  1982年   8909篇
  1979年   17122篇
  1978年   11468篇
  1977年   10248篇
  1976年   8906篇
  1975年   10073篇
  1974年   11683篇
  1973年   11280篇
  1972年   10756篇
  1971年   10093篇
  1970年   9282篇
  1969年   8975篇
  1968年   7943篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis.  相似文献   
53.
54.
55.
56.
57.
58.
59.
The aim of the present study was to evaluate the antimicrobial activity of two synbiotic combinations, Lactobacillus fermentum with short-chain fructooligosaccharides (FOS-LF) and Bifidobacterium longum with isomaltooligosaccharides (IMO-BL), against enterohaemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O86. Antimicrobial activity was determined (1) by co-culturing the synbiotics and pathogens in batch cultures, and (2) with the three-stage continuous culture system (gut model), inoculated with faecal slurry from an elderly donor. In the co-culture experiments, IMO-BL was significantly inhibitory to both E. coli strains, while FOS-LF was slightly inhibitory or not inhibitory. Factors other than acid production appeared to play a role in the inhibition. In the gut models, both synbiotics effectively inhibited E. coli O157 in the first vessel, but not in vessels 2 and 3. E. coli O86 was not significantly inhibited.  相似文献   
60.
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号